Alev Türker

1.1k total citations
42 papers, 392 citations indexed

About

Alev Türker is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alev Türker has authored 42 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alev Türker's work include Lymphoma Diagnosis and Treatment (12 papers), Sarcoma Diagnosis and Treatment (7 papers) and Cancer Treatment and Pharmacology (6 papers). Alev Türker is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Sarcoma Diagnosis and Treatment (7 papers) and Cancer Treatment and Pharmacology (6 papers). Alev Türker collaborates with scholars based in Türkiye, United Kingdom and India. Alev Türker's co-authors include Ayşe Kars, Sercan Aksoy, Mustafa Erman, Başak Oyan, Saadettin Kılıçkap, Kadri Altundağ, Gülten Tekuzman, Alp Usubutün, Anna Porwit‐MacDonald and Didem Şener Dede and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Alev Türker

36 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alev Türker Türkiye 12 161 119 90 73 64 42 392
Jong Hyung Yoon South Korea 11 76 0.5× 133 1.1× 45 0.5× 84 1.2× 83 1.3× 22 386
Bungo Saito Japan 14 164 1.0× 59 0.5× 205 2.3× 102 1.4× 76 1.2× 47 485
R. Jyothirmayi United Kingdom 13 120 0.7× 142 1.2× 79 0.9× 37 0.5× 49 0.8× 30 485
Michael J. Warzynski United States 11 146 0.9× 90 0.8× 71 0.8× 82 1.1× 46 0.7× 23 463
Roberta Babare Italy 8 192 1.2× 120 1.0× 106 1.2× 142 1.9× 103 1.6× 13 597
Shripad Banavali India 13 145 0.9× 180 1.5× 33 0.4× 104 1.4× 67 1.0× 37 483
Andrew J. Klink United States 13 149 0.9× 151 1.3× 136 1.5× 39 0.5× 102 1.6× 61 524
İnci Alacacıoğlu Türkiye 12 157 1.0× 36 0.3× 123 1.4× 36 0.5× 51 0.8× 46 383
Stuart Toledano United States 13 97 0.6× 145 1.2× 41 0.5× 36 0.5× 103 1.6× 32 467
Annalisa Serra Italy 14 80 0.5× 102 0.9× 134 1.5× 52 0.7× 164 2.6× 47 520

Countries citing papers authored by Alev Türker

Since Specialization
Citations

This map shows the geographic impact of Alev Türker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alev Türker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alev Türker more than expected).

Fields of papers citing papers by Alev Türker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alev Türker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alev Türker. The network helps show where Alev Türker may publish in the future.

Co-authorship network of co-authors of Alev Türker

This figure shows the co-authorship network connecting the top 25 collaborators of Alev Türker. A scholar is included among the top collaborators of Alev Türker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alev Türker. Alev Türker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Onur, Mehmet Ruhi, Necla Özer, Yusuf Ziya Şener, et al.. (2021). Sarcopenia and anthracycline cardiotoxicity in patients with cancer. BMJ Supportive & Palliative Care. 13(4). 453–461. 8 indexed citations
2.
Onur, R., Deniz Can Güven, Salih Aksu, et al.. (2020). 1504O Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer. Annals of Oncology. 31. S932–S932.
3.
Güven, Deniz Can, Taha Koray Şahin, Neyran Kertmen, et al.. (2020). COVID-19 pandemic: changes in cancer admissions. BMJ Supportive & Palliative Care. 14(e1). e376–e379. 26 indexed citations
4.
Güven, Deniz Can, Taha Koray Şahin, Neyran Kertmen, et al.. (2020). 1724P Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients. Annals of Oncology. 31. S1011–S1011. 1 indexed citations
5.
Akın, Serkan, et al.. (2018). Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma. Current Problems in Cancer. 42(3). 344–349. 8 indexed citations
6.
7.
Selek, Uğur, Faruk Zorlu, Pervin Hürmüz, et al.. (2007). Craniospinal Radiotherapy in Adult Medulloblastoma. Strahlentherapie und Onkologie. 183(5). 236–240. 19 indexed citations
8.
Aksoy, Sercan, Saadettin Kılıçkap, Mutlu Hayran, et al.. (2007). Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. International Journal of Laboratory Hematology. 30(3). 214–219. 47 indexed citations
9.
Oyan, Başak, Yener Koç, Evren Özdemir, et al.. (2006). High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma. Leukemia & lymphoma. 47(8). 1545–1552. 15 indexed citations
10.
Oyan, Başak, Yener Koç, Ayşe Kars, et al.. (2005). IIVP Salvage Regimen Induces High Response Rates in Patients With Relapsed Lymphoma Before Autologous Stem Cell Transplantation. American Journal of Clinical Oncology. 28(3). 264–269. 6 indexed citations
11.
Oyan, Başak, Yener Koç, Evren Özdemir, et al.. (2005). Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(9). 688–697. 11 indexed citations
12.
13.
Altundağ, Kadri, Oğuz Dikbaş, Başak Oyan, Alp Usubutün, & Alev Türker. (2004). Epithelioid Sarcoma of Vulva: A Case Report and Review of the Literature. Medical Oncology. 21(4). 367–372. 21 indexed citations
14.
Öztürk, Mehmet Akif, İbrahim Barışta, M. Kadri Altundağ, et al.. (2002). Modified ESHAP as Salvage Chemotherapy for Recurrent or Refractory Non-Hodgkin’s Lymphoma: Results of a Single-Center Study of 32 Patients. Chemotherapy. 48(5). 252–258. 15 indexed citations
15.
Altundağ, M. Kadri, Hüseyin Engin, Özden Altundağ, et al.. (2001). Hypereosinophilia and Metastatic Anaplastic Carcinoma of Unknown Primary. Medical Oncology. 18(4). 285–288. 4 indexed citations
16.
Türker, Alev & Serdar Özgen. (2000). Local Anesthesia for Extracorporeal Shock Wave Lithotripsy: A Double–Blind, Prospective, Randomized Study. European Urology. 37(3). 331–333. 5 indexed citations
17.
Türker, Alev & Nilüfer Güler. (1999). Therapy related acute myeloid leukemia after exposure to 5-Fluorouracil: a case report. PubMed. 41(5). 195–196. 8 indexed citations
18.
Zengin, Nurullah, Ayşe Kars, Yavuz Özışık, et al.. (1998). Aleukemic leukemia cutis in a patient with acute lymphoblastic leukemia. Journal of the American Academy of Dermatology. 38(4). 620–621. 15 indexed citations
19.
Kars, Ayşe, İ. Çelik, Emin Kansu, et al.. (1997). Maintenance therapy with alpha‐interferon following first‐line VAD in multiple myeloma. European Journal Of Haematology. 59(2). 100–104. 8 indexed citations
20.
Çavdar, A.O., Işık Bökesoy, Asuman Sunguroğlu, et al.. (1993). Orbito-Ocular Granulocytic Sarcoma (OOGS) and Acute Myeloblastic Leukemia (AML) with duplication of philadelphia chromosome. Cancer Genetics and Cytogenetics. 69(1). 38–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong Hyung Yoon Breakdown of academic impact, for papers by Bungo Saito Breakdown of academic impact, for papers by R. Jyothirmayi Breakdown of academic impact, for papers by Michael J. Warzynski Breakdown of academic impact, for papers by Roberta Babare Breakdown of academic impact, for papers by Shripad Banavali Breakdown of academic impact, for papers by Andrew J. Klink Breakdown of academic impact, for papers by İnci Alacacıoğlu Breakdown of academic impact, for papers by Stuart Toledano Breakdown of academic impact, for papers by Annalisa Serra
Rankless by CCL
2026